MCC950 was found to effectively hinder the activation of the NLRP3 inflammasome and the subsequent release of interleukin-1β, leading to a significant reduction in mortality rates in mice with cryopyrin-associated periodic syndrome, a condition caused by abnormal NLRP3 inflammasome activation [144]. The gene discussed is NLRP3; the disease is cryopyrin-associated periodic syndrome.